Notice of Funding Opportunity for Alzheimer's Disease and Related Dementias Clinical Trials
National Institutes of Health
Description
This grant opportunity focuses on supporting early-stage clinical trials for new treatments targeting Alzheimer's disease and related dementias. It combines initial phase 1 and early phase 1b/2a trials into one process. Eligible interventions should target mechanisms other than amyloid and tau proteins and aim to improve cognitive and/or neuropsychiatric symptoms across different stages of the disease. Applications need to include criteria for assessing safety and tolerability to determine w…
This NOFO aims to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease and related dementias by bundling phase 1 and phase 1b/phase 2a clinical trials. The interventions must engage non-amyloid/non-tau mechanisms and address cognitive and/or ne…
Source
Grant ID
PAR-25-226
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Aging
Key Dates
Opportunity Released
November 22, 2024
Eligibility
The following categories of applicants are invited to apply:
- Regional Organizations
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Independent School Districts
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- Local Governments
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Non-domestic (non-U.S.) components of U.S. Organizations
- Foreign components (as defined in the NIH Grants Policy Statement) are allowed
- Non-domestic (non-U.S.) Entities (Foreign Organizations)
Similar opportunities
- Notice of Funding Opportunity for Studies on Neuropsychiatric Symptoms in Alzheimer's Disease
National Institutes of Health
- Notice of Funding Opportunity for Studies on Neuropsychiatric Symptoms in Alzheimer's Disease
National Institutes of Health
- Notice of Special Interest (NOSI): Novel Approaches to Characterizing and Diagnosing Alzheimer's Disease and Related Dementias
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Preclinical Testing of Drugs for Alzheimer's Disease
National Institutes of Health
- Notice of Funding Opportunity for Pre-clinical and Early Stage Clinical Development of Drug Candidates for Alzheimer's Disease
National Institutes of Health